Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transfusional Iron Overload”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01511848
What this trial is testing

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Who this might be right for
Beta-thalassemia MajorSickle Cell DiseaseIron Hemosiderosis
Ain Shams University 60
Post-approval studies (Phase 4)Ended earlyNCT01326845
What this trial is testing

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study

Who this might be right for
Myelodysplastic SyndromeTransfusional Iron Overload
Novartis Pharmaceuticals 12
Post-approval studies (Phase 4)Study completedNCT01736540
What this trial is testing

An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

Who this might be right for
Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
Novartis Pharmaceuticals 243
Testing effectiveness (Phase 2)Study completedNCT01186419
What this trial is testing

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
Shire 51
Testing effectiveness (Phase 2)Study completedNCT00110266
What this trial is testing

Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients

Who this might be right for
Myelodysplastic SyndromeIron Overload
Novartis Pharmaceuticals 176
Early research (Phase 1)Ended earlyNCT04741542
What this trial is testing

Safety of SP-420 in the Treatment of Transfusional Iron Overload

Who this might be right for
Iron Overload
The University of Texas Health Science Center at San Antonio 2
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Study completedNCT00631163
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Who this might be right for
Chronic AnemiaTransfusional Hemosiderosis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)WithdrawnNCT01892644
What this trial is testing

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

Who this might be right for
HemochromatosisMyelodysplastic Syndromes
Haukeland University Hospital
Testing effectiveness (Phase 2)Study completedNCT00303329
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Who this might be right for
AnemiaHemosiderosis
Novartis Pharmaceuticals 184
Not applicableStudy completedNCT04171635
What this trial is testing

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

Who this might be right for
MRI Scans
Weill Medical College of Cornell University 55
Testing effectiveness (Phase 2)Ended earlyNCT01363908
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-Thalassemia
Shire 30
Testing effectiveness (Phase 2)Study completedNCT00069862
What this trial is testing

Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia

Who this might be right for
Beta-Thalassemia
Genzyme, a Sanofi Company 25
Early research (Phase 1)Study completedNCT01039636
What this trial is testing

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
FerroKin BioSciences, Inc. 20
Post-approval studies (Phase 4)Study completedNCT01335035
What this trial is testing

Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload

Who this might be right for
Iron Overload
Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT00235391
What this trial is testing

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

Who this might be right for
ThalassemiaSickle Cell DiseaseDiamond Blackfan Anemia+1 more
Novartis Pharmaceuticals 1,683
Testing effectiveness (Phase 2)Study completedNCT01044186
What this trial is testing

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 30
Not applicableStudy completedNCT01369719
What this trial is testing

Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload

Who this might be right for
ThalassemiaIron OverloadTransfusion Related Complications
Hormozgan University of Medical Sciences 138
Testing effectiveness (Phase 2)WithdrawnNCT01927913
What this trial is testing

Treatment of Iron Overload Requiring Chelation Therapy

Who this might be right for
Transfusional Iron OverloadIron OverloadIron Chelation+4 more
Shire
Not applicableStudy completedNCT00466063
What this trial is testing

ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

Who this might be right for
Anemia
Novartis Pharmaceuticals 108
Next Page